Vimarsana
Biggest News Aggregation in the World

Page 23 - Study Lead Author News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Study Lead Author. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Study Lead Author Today - Breaking & Trending Today

New Way to Mass Produce Cheaper, Lighter Perovskite Solar Cells - Vimarsana News

New Way to Mass Produce Cheaper, Lighter Perovskite Solar Cells

A significant scientific advancement from the researchers at the University of Surrey's Advanced Technology Institute (ATI) is moving closer to mass-producing the next generation of more affordable and lightweight perovskite solar cells.

Source: azom.com
Graphene By-Product Compensates "Flash" Hydrogen Production Expenses - Vimarsana News

Graphene By-Product Compensates "Flash" Hydrogen Production Expenses

Hydrogen is seen as a possible replacement for fossil fuels, but the technologies utilized to produce it either emit too much CO2 or are too expensive.

New AI System Helps Prevent Blindness Across the Globe - Vimarsana News

New AI System Helps Prevent Blindness Across the Globe

At University College London (UCL) and Moorfields Eye Hospital, scientists have come up with an artificial intelligence (AI) system that could not just determine sight-threatening eye diseases but also forecast general health, such as stroke, heart attacks, and Parkinson’s disease.

ChatGPT can debunk vaccine myths and increase vaccine uptake, study finds - Vimarsana News

ChatGPT can debunk vaccine myths and increase vaccine uptake, study finds

ChatGPT could help to increase vaccine uptake by debunking myths around jab safety, say the authors of a study published in the peer-reviewed journal Human Vaccines and Immunotherapeutics.

New cancer therapy shows promise in mouse models, slows or reverses tumor growth - Vimarsana News

New cancer therapy shows promise in mouse models, slows or reverses tumor growth

A new cancer therapy developed by Purdue University researchers attacks tumors by tricking cancer cells into absorbing a snippet of RNA that naturally blocks cell division.